Therapeutic efficacy of anti-ErbB2 immunoliposomes targeted by a phage antibody selected for cellular endocytosis
- 1 July 2002
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1591 (1-3), 109-118
- https://doi.org/10.1016/s0167-4889(02)00256-2
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Biological Effects of Anti-ErbB2 Single Chain Antibodies Selected for Internalizing FunctionBiochemical and Biophysical Research Communications, 2001
- Selection of tumor-specific internalizing human antibodies from phage librariesJournal of Molecular Biology, 2000
- Toward Selection of Internalizing Antibodies from Phage LibrariesBiochemical and Biophysical Research Communications, 1999
- The role of structure in antibody cross-reactivity between peptides and folded proteinsJournal of Molecular Biology, 1998
- Isolation of Picomolar Affinity Anti-c-erbB-2 Single-chain Fv by Molecular Evolution of the Complementarity Determining Regions in the Center of the Antibody Binding SiteJournal of Molecular Biology, 1996
- Mapping the detailed specificity of a calcium-dependent monoclonal antibody through the use of soluble positional scanning combinatorial libraries: Identification of potent calcium-independent antigensMolecular Diversity, 1995
- Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol) s conjugated at their distal terminals to monoclonal antibodiesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1995
- In vitro cytotoxicity of liposome-encapsulated doxorubicin: dependence on liposome composition and drug releaseBiochimica et Biophysica Acta (BBA) - Biomembranes, 1992
- By-passing immunizationJournal of Molecular Biology, 1991
- The influence of coupling transferrin to liposomes or minibeads on its uptake and fate in leukemic L2C cellsFEBS Letters, 1987